Related references
Note: Only part of the references are listed.Financial Relationships Between Pharmaceutical Companies and Rheumatologists in Japan Between 2016 and 2019
Anju Murayama et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2023)
Evaluation of financial conflicts of interest and quality of evidence in Japanese gastroenterology clinical practice guidelines
Anju Murayama et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2023)
Letter to the editor: Are clinical practice guidelines for hepatitis C by the American Association for the Study of Liver Diseases and Infectious Diseases Society of America evidence based? Financial conflicts of interest and assessment of quality of evidence and strength of recommendations
Anju Murayama et al.
HEPATOLOGY (2022)
General practitioners and sales representatives: Why are we so ambivalent?
Adriaan Barbaroux et al.
PLOS ONE (2022)
Sunshine on KOLs: assessment of the nature, extent and evolution of financial ties between the leaders of professional medical associations and the pharmaceutical industry in France from 2014 to 2019: a retrospective study
Marie Clinckemaillie et al.
BMJ OPEN (2022)
Evaluation of Conflicts of Interest among Participants of the Japanese Nephrology Clinical Practice Guideline
Anju Murayama et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2022)
Financial and Intellectual Conflicts of Interest Among Japanese Clinical Practice Guidelines Authors for Allergic Rhinitis
Anju Murayama et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2022)
Pharmaceutical payments to Japanese certified hematologists: a retrospective analysis of personal payments from pharmaceutical companies between 2016 and 2019
Eiji Kusumi et al.
BLOOD CANCER JOURNAL (2022)
Awareness and Perceptions among Members of a Japanese Cancer Patient Advocacy Group Concerning the Financial Relationships between the Pharmaceutical Industry and Physicians
Anju Murayama et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)
Industry payments to allergists and clinical immunologists in the United States during the coronavirus disease 2019 pandemic
Anju Murayama et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2022)
Evaluation of financial relationships between Japanese certified pediatric hematologist/oncologists and pharmaceutical companies: a cross-sectional analysis of personal payments from pharmaceutical companies between 2016 and 2019
Sae Kamamoto et al.
PEDIATRIC BLOOD & CANCER (2022)
Pharmaceutical Payments to Japanese Board-Certified Infectious Disease Specialists: A Four-Year Retrospective Analysis of Payments from 92 Pharmaceutical Companies between 2016 and 2019
Anju Murayama et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)
Nature and Trends in Personal Payments Made to the Respiratory Physicians by Pharmaceutical Companies in Japan between 2016 and 2019
Anju Murayama et al.
RESPIRATION (2022)
Are Financial Payments From the Pharmaceutical Industry Associated With Physician Prescribing? A Systematic Review
Aaron P. Mitchell et al.
ANNALS OF INTERNAL MEDICINE (2021)
Pharmaceutical company payments to authors of the Japanese Clinical Practice Guidelines for Hepatitis C treatment
Futa Kida et al.
LIVER INTERNATIONAL (2021)
Trends in Industry Payments to Medical Oncologists in the United States Since the Inception of the Open Payments Program, 2014 to 2019
Elizabeth S. Tarras et al.
JAMA ONCOLOGY (2021)
Discordant and inappropriate discordant recommendations in consensus and evidence based guidelines: empirical analysis
Liang Yao et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Breaking the therapeutic ceiling in drug development in ulcerative colitis
Dahham Alsoud et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)
Financial conflicts of interest between pharmaceutical companies and the authors of urology clinical practice guidelines in Japan
Kana Yamamoto et al.
INTERNATIONAL UROGYNECOLOGY JOURNAL (2021)
Undisclosed payments by pharmaceutical and medical device manufacturers to authors of endoscopy guidelines in the United States
Rishi Bansal et al.
GASTROINTESTINAL ENDOSCOPY (2020)
Association between Opioid Prescribing in Medicare and Pharmaceutical Company Gifts by Physician Specialty
Mara A. G. Hollander et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2020)
Overview and transparency of non-research payments to healthcare organizations and healthcare professionals from pharmaceutical companies in Japan: Analysis of payment data in 2016
Akihiko Ozaki et al.
HEALTH POLICY (2020)
Financial ties between leaders of influential US professional medical associations and industry: cross sectional study
Ray Moynihan et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Pharmaceutical company payments to dermatology Clinical Practice Guideline authors in Japan
Anju Murayama et al.
PLOS ONE (2020)
Association between conflicts of interest and favourable recommendations in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: systematic review
Camilla H. Nejstgaard et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Analysis of payments to GI physicians in theUnited States: Open payments data study
Venu Gopala Reddy Gangireddy et al.
JGH OPEN (2020)
Clinical practice guidelines and the overuse of health care services: need for reform
Ismail Jatoi et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2019)
Pharmaceutical Company Payments to Executive Board Members of Professional Medical Associations in Japan
Hiroaki Saito et al.
JAMA INTERNAL MEDICINE (2019)
Financial relationships between neurologists and industry The 2015 Open Payments database
Aditi Ahlawat et al.
NEUROLOGY (2019)
Undisclosed financial conflicts of interest among authors of American Society of Clinical Oncology clinical practice guidelines
Ramy R. Saleh et al.
CANCER (2019)
Association of Biologic Prescribing for Inflammatory Bowel Disease With Industry Payments to Physicians
Rishad Khan et al.
JAMA INTERNAL MEDICINE (2019)
Pharmaceutical payments to certified oncology specialists in Japan in 2016: a retrospective observational cross-sectional analysis
Akihiko Ozaki et al.
BMJ OPEN (2019)
Association between physician characteristics and payments from industry in 2015-2017: observational study
Kosuke Inoue et al.
BMJ OPEN (2019)
Association between gifts from pharmaceutical companies to French general practitioners and their drug prescribing patterns in 2016: retrospective study using the French Transparency in Healthcare and National Health Data System databases
Bruno Goupil et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Can We Trust the Independence of Cardiovascular Guidelines?
Steven E. Nissen
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2019)
Analysis of American College of Cardiology/American Heart Association Guideline Author Self-Disclosure Compared With Open Payments Industry Disclosure
Ramzi Dudum et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2019)
Financial Conflicts of Interest in Inflammatory Bowel Disease Guidelines
Alexander W. Grindal et al.
INFLAMMATORY BOWEL DISEASES (2019)
Industry Payments to Physicians and Prescriptions of Brand-Name Proton-Pump Inhibitors
Elliot Morse et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2019)
Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in Japan
Hiroaki Saito et al.
JAMA NETWORK OPEN (2019)
Analysis of Pharmaceutical Industry Payments to UK Health Care Organizations in 2015
Piotr Ozieranski et al.
JAMA NETWORK OPEN (2019)
The Evidence Basis for the American College of Rheumatology Practice Guidelines
Ali Duarte-Garcia et al.
JAMA INTERNAL MEDICINE (2018)
Prevalence of Financial Conflicts of Interest Among Authors of Clinical Guidelines Related to High-Revenue Medications
Rishad Khan et al.
JAMA INTERNAL MEDICINE (2018)
Sunshine Policies and Murky Shadows in Europe: Disclosure of Pharmaceutical Industry Payments to Health Professionals in Nine European Countries
Alice Fabbri et al.
INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT (2018)
Assessment of Pharmaceutical Company and Device Manufacturer Payments to Gastroenterologists and Their Participation in Clinical Practice Guideline Panels
Salman Nusrat et al.
JAMA NETWORK OPEN (2018)
Industry Payments to Physician Specialists Who Prescribe Repository Corticotropin
Daniel M. Hartung et al.
JAMA NETWORK OPEN (2018)
Types and Distribution of Payments From Industry to Physicians in 2015
Kathryn R. Tringale et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Breaking Down Barriers to Care in Hepatitis C Virus Infection
Mark Thursz et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Financial Relationships between Organizations That Produce Clinical Practice Guidelines and the Biomedical Industry: A Cross-Sectional Study
Paul Campsall et al.
PLOS MEDICINE (2016)
Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries
Colette DeJong et al.
JAMA INTERNAL MEDICINE (2016)
Guidelines International Network: Principles for Disclosure of Interests and Management of Conflicts in Guidelines
Holger J. Schunemann et al.
ANNALS OF INTERNAL MEDICINE (2015)
How to make opinion leaders and influence people
Sergio Sismondo
CANADIAN MEDICAL ASSOCIATION JOURNAL (2015)
Act II of the Sunshine Act
Genevieve Pham-Kanter
PLOS MEDICINE (2014)
Key Opinion Leaders and the Corruption of Medical Knowledge: What the Sunshine Act Will and Won't Cast Light On
Sergio Sismondo
JOURNAL OF LAW MEDICINE & ETHICS (2013)
Ensuring the integrity of clinical practice guidelines: a tool for protecting patients
Jeanne Lenzer et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Perspective: Conflict of Interest and Professional Organizations: Considerations and Recommendations
Michael Camilleri et al.
ACADEMIC MEDICINE (2010)
Key opinion leaders: where they come from and how that affects the drugs you prescribe
Jeffrey J. Meffert
DERMATOLOGIC THERAPY (2009)
Professional Medical Associations and Their Relationships With Industry A Proposal for Controlling Conflict of Interest
David J. Rothman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Attorney General forces Infectious Diseases Society of America to redo Lyme guidelines due to flawed development process
L. Johnson et al.
JOURNAL OF MEDICAL ETHICS (2009)
A national survey of physician-industry relationships
Eric G. Campbell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
A modified Poisson regression approach to prospective studies with binary data
GY Zou
AMERICAN JOURNAL OF EPIDEMIOLOGY (2004)
Share Paper
